Abacavir
Side effects
Options:
Show MedDRA Preferred Terms
Side effect
|
Data for drug
|
Placebo
|
Labels
|
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
Malaise
|
0.971% - 33.7%
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Pruritus
|
17%
|
|
|
|
|
|
|
x
|
|
|
|
Vomiting
|
common, 11.1% - 38.2%
|
|
x
|
x
|
x
|
|
x
|
x
|
x
|
x
|
x
|
Myalgia
|
13%
|
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
Chills
|
12%
|
|
x
|
x
|
x
|
|
|
x
|
|
|
|
Cough
|
6.17% - 23.5%
|
|
|
|
|
|
|
x
|
x
|
|
x
|
Diarrhoea
|
common, 5.47% - 18%
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Nausea
|
common, 1.94% - 47%
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Headache
|
common, 5.44% - 31.3%
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Drug hypersensitivity
|
6.99% - 9.11%
|
|
x
|
x
|
x
|
x
|
|
x
|
|
x
|
|
Insomnia
|
6.77% - 9.33%
|
|
|
|
|
x
|
x
|
x
|
|
|
|
Infection
|
3.61% - 18.6%
|
|
|
|
|
|
|
x
|
|
|
|
Depression
|
6.51% - 6.74%
|
|
|
|
|
x
|
|
x
|
|
|
|
Pain
|
3.61% - 7.41%
|
|
x
|
x
|
x
|
|
|
x
|
|
|
|
Abdominal discomfort
|
3.61% - 7.41%
|
|
|
|
|
|
|
x
|
|
|
|
Fatigue
|
common, 0.971% - 33.7%
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Anorexia
|
common
|
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
Rash
|
very rare — 4.82% - 68%
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Body temperature increased
|
common, 3.37% - 83%
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Lethargy
|
common
|
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
Hyperlactacidaemia
|
common
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
Dizziness
|
4.92% - 4.95%
|
|
x
|
x
|
x
|
x
|
|
x
|
|
|
|
Abnormal dreams
|
3.91% - 4.92%
|
|
|
|
|
x
|
|
x
|
|
|
|
Musculoskeletal pain
|
2.94% - 7.23%
|
|
x
|
x
|
x
|
|
|
x
|
|
|
|
Anxiety
|
3.12% - 5.18%
|
|
x
|
x
|
x
|
x
|
|
x
|
|
|
|
Sleep disorder
|
0% - 7.23%
|
|
x
|
x
|
x
|
|
|
x
|
|
|
|
Neuropathy
|
0.971% - 3.7%
|
|
|
|
|
|
|
x
|
|
|
|
Lactic acidosis
|
very rare — rare
|
|
x
|
x
|
x
|
x
|
|
x
|
x
|
x
|
x
|
Toxic epidermal necrolysis
|
very rare, postmarketing
|
|
x
|
x
|
x
|
x
|
|
x
|
x
|
x
|
x
|
Erythema multiforme
|
very rare, postmarketing
|
|
x
|
x
|
x
|
x
|
|
x
|
x
|
x
|
x
|
Hypersensitivity
|
postmarketing
|
|
x
|
|
x
|
|
|
|
|
|
|
Myocardial infarction
|
postmarketing
|
|
x
|
x
|
x
|
x
|
|
|
|
|
|
Pancreatitis
|
rare
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Stevens-Johnson syndrome
|
very rare, postmarketing
|
|
x
|
x
|
x
|
x
|
|
x
|
x
|
x
|
x
|
Hepatic steatosis
|
very rare, postmarketing
|
|
x
|
x
|
x
|
x
|
|
|
|
x
|
x
|
Hepatomegaly
|
very rare
|
|
|
x
|
x
|
|
|
|
|
x
|
x
|
Abdominal pain
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
AIDS dementia complex
|
|
|
|
|
|
|
|
|
|
x
|
|
Alopecia
|
|
|
|
|
|
x
|
|
|
|
|
|
Anaphylactic shock
|
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
Anaemia
|
|
|
x
|
x
|
x
|
x
|
x
|
|
|
|
|
Aplastic anaemia
|
|
|
|
|
|
x
|
|
|
|
|
|
Arthralgia
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
Asthenia
|
|
|
|
|
|
x
|
|
|
|
|
|
Autoimmune disorder
|
|
|
|
|
|
|
|
|
|
|
x
|
Bronchitis
|
|
|
x
|
x
|
x
|
|
|
x
|
x
|
x
|
x
|
Conjunctivitis
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
Depressive disorder
|
|
|
x
|
x
|
x
|
|
|
|
|
|
|
Dyspnoea
|
|
|
|
|
|
|
x
|
x
|
x
|
|
x
|
Oedema
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
Gastritis
|
|
|
x
|
x
|
x
|
x
|
|
|
|
|
|
Gastroenteritis
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
Gastrointestinal disorder
|
|
|
|
|
|
|
|
|
x
|
|
x
|
Basedow's disease
|
|
|
|
|
|
|
|
|
|
|
x
|
Hepatitis
|
|
|
|
|
|
|
|
|
|
|
x
|
Hepatitis B
|
|
|
|
|
|
x
|
|
|
|
|
|
Hypercholesterolaemia
|
|
|
|
|
|
|
|
|
|
|
x
|
Hyperglycaemia
|
|
|
x
|
x
|
x
|
x
|
|
|
|
|
x
|
Hypertriglyceridaemia
|
|
|
x
|
x
|
x
|
|
|
|
|
|
x
|
Hypertrophy of breast
|
|
|
|
|
|
|
|
|
|
|
x
|
Hypotension
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
Inflammation
|
|
|
|
|
|
|
|
|
|
|
x
|
Insulin resistance
|
|
|
|
|
|
|
|
|
|
|
x
|
Leukopenia
|
|
|
x
|
x
|
x
|
|
|
|
|
|
|
Lipodystrophy
|
|
|
|
|
|
|
|
|
|
|
x
|
Lymphopenia
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
Nervous system disorder
|
|
|
|
|
|
|
|
|
x
|
x
|
x
|
Neutropenia
|
|
|
x
|
x
|
x
|
x
|
x
|
|
|
|
|
Opportunistic infection
|
|
|
|
|
|
|
|
|
|
|
x
|
Paraesthesia
|
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
Neuropathy peripheral
|
|
|
|
|
|
x
|
|
|
|
|
|
Pharyngitis
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
Pneumonia
|
|
|
x
|
x
|
x
|
|
|
x
|
x
|
|
x
|
Aplasia pure red cell
|
|
|
|
|
|
x
|
|
|
|
|
|
Renal failure
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
Acute respiratory distress syndrome
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
Respiratory tract infection
|
|
|
x
|
x
|
x
|
|
|
|
|
|
|
Rhabdomyolysis
|
|
|
|
|
|
x
|
|
|
|
|
|
Convulsion
|
|
|
|
|
|
x
|
|
|
|
x
|
|
Gastrointestinal signs and symptoms
|
|
|
x
|
x
|
x
|
|
|
|
|
|
|
Splenomegaly
|
|
|
|
|
|
x
|
|
|
|
|
|
Stomatitis
|
|
|
|
|
|
x
|
|
|
|
|
|
Thrombocytopenia
|
|
|
x
|
x
|
x
|
x
|
|
|
|
|
|
Urticaria
|
|
|
|
|
|
x
|
|
|
|
|
|
Vertigo
|
|
|
|
|
|
x
|
|
|
|
|
|
Wheezing
|
|
|
|
|
|
x
|
|
|
|
|
|
Hepatic failure
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
Mouth ulceration
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
Migraine
|
|
|
x
|
x
|
x
|
x
|
|
|
|
|
|
Creatine phosphokinase increased
|
|
|
x
|
x
|
x
|
|
|
|
|
|
|
Creatinine increased
|
|
|
|
|
|
|
|
|
x
|
x
|
x
|
Gamma-glutamyltransferase increased
|
|
|
x
|
x
|
x
|
x
|
x
|
|
|
|
|
Muscular weakness
|
|
|
|
|
|
x
|
|
|
|
|
|
Aspartate aminotransferase increased
|
|
|
x
|
x
|
x
|
|
|
x
|
|
|
|
Alanine aminotransferase increased
|
|
|
x
|
x
|
x
|
|
|
x
|
|
|
|
Malnutrition
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
Unspecified disorder of skin and subcutaneous tissue
|
|
|
|
|
|
|
|
|
x
|
x
|
x
|
Fatal outcomes
|
|
|
|
|
|
|
|
x
|
|
|
x
|
Hyperamylasaemia
|
|
|
x
|
x
|
x
|
|
|
|
|
|
|
Breath sounds abnormal
|
|
|
|
|
|
x
|
|
|
|
|
|
Other sleep disturbances
|
|
|
|
|
|
|
x
|
|
|
|
|
Throat sore
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
Blood bilirubin increased
|
|
|
|
|
|
x
|
|
|
|
|
|
Depressed mood
|
|
|
|
|
|
x
|
|
|
|
|
|
Gastrointestinal symptom NOS
|
|
|
|
|
|
|
x
|
|
|
|
|
Lymphadenopathy
|
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
Buffalo hump
|
|
|
|
|
|
|
|
|
|
|
x
|
Influenza like illness
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
Fat redistribution
|
|
|
|
x
|
x
|
x
|
|
|
|
|
|
Raised liver function tests
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
Respiratory failure
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
Sensitisation
|
|
|
|
|
|
x
|
|
|
|
|
|
Appetite absent
|
|
|
|
|
|
|
x
|
|
|
|
|
Indications
Information about indications was extracted from the indications and usage sections of the labels.
Side effects: | 42 |
Source: | FDA Structured Product Label |
---|
Side effects: | 43 |
Source: | FDA Structured Product Label |
---|
Side effects: | 44 |
Source: | FDA Structured Product Label |
---|
Side effects: | 50 |
Source: | FDA Structured Product Label |
---|
Side effects: | 33 |
Source: | FDA |
---|
Side effects: | 58 |
Source: | medicines.org.au |
---|
Side effects: | 45 |
Source: | Medsafe |
---|
Side effects: | 46 |
Source: | Health Canada |
---|
Side effects: | 60 |
Source: | EMA |
---|
Color scheme:
standard – alternative
|
|
100%
|
|
|
75%
|
|
|
50%
|
|
|
10%
|
|
|
frequent (1% to 100%)
|
|
|
infrequent (0.1% to 1%)
|
|
|
rare (<0.1%)
|
|
|
postmarketing
|
|
|
0%
|
|
|
no frequency information
|
|
|
not found on label
|